FDA Drug Recalls

Recalls / Class I

Class ID-0316-2024

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Robitussin Honey CF Max Non-Drowsy Adult (Acetaminophen 650mg, Dextromethorphan HBr 20 mg), a) 4 FL OZ (118mL) and b) 8 FL OZ (237 mL) bottles, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059

Affected lot / code info
a) Lot#: T10810, Exp 10/31/2025 b) Lot#: T08730, T08731, T08732, T08733, Exp 05/31/2025; T10808, Exp 09/30/2025

Why it was recalled

Microbial Contamination of Non-Sterile Products

Recalling firm

Firm
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
184 Liberty Corner Rd, N/A, Warren, New Jersey 07059-6796

Distribution

Quantity
a) 31,632 bottles; b) 336,528 bottles
Distribution pattern
USA nationwide

Timeline

Recall initiated
2023-12-26
FDA classified
2024-02-07
Posted by FDA
2024-01-31
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0316-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.